CMT-ATP6

MT-ATP6 | 2019

What Is CMT-ATP6?

CMT-ATP6 is a type of CMT caused by mutations in the MT-ATP6 gene. This gene lives in mitochondrial DNA rather than regular coding DNA, and provides instructions for making a component of the enzyme that generates cellular energy within mitochondria. Mutations in the MT-ATP6 gene disrupt this function, leading to impaired nerve signal transmission.

CMT-ATP6 follows a mitochondrial inheritance pattern, meaning the causative mutation is carried in the mitochondrial DNA and passed from a mother to her children.

Clinical Features

The age of symptom onset in CMT-ATP6 is variable, ranging from childhood to adulthood. Symptoms typically begin in the lower extremities and progress over time to involve the upper limbs. Nerve conduction studies usually show somewhat slowed conduction velocities and reduced amplitudes, consistent with an axonal form of CMT.

CMT-ATP6 symptoms may include:

  • Weakness in the feet and lower legs
  • Muscle atrophy
  • Foot drop
  • Reduced or absent reflexes
  • Reduced sensation
  • A steppage-style walking pattern
  • Foot deformities, including high arches, and hammertoes (clawed toes)
  • Progressive involvement of the hands and forearms
  • Difficulty with fine motor skills and manual dexterity
  • Additional symptoms not listed here

Disease Course

CMT-ATP6 shows wide variability in severity and progression. Some individuals are mildly affected, while others develop a more severe disease. Disease progression is generally slow, and life expectancy is not reduced.

Clinical Basics

Subtype
CMT-ATP6

Classification
Unclassified Subtypes

Neuropathy Type
Axonal

Inheritance Pattern
mitochondrial inheritance

Genetic Context

HGNC-Approved Gene Symbol
MT-ATP6

Gene Full Name
mitochondrially encoded ATP synthase membrane subunit 6

Chromosome
MT

Zygosity of Responsible Variant
Homoplasmic

Mitochondrial Involvement
Yes

Variant Mechanism

Loss of Function (LoF)

Details

Mechanistic basis:
Hypomorphic

Confidence:
Medium

Prediction:
The literature attributes CMT-ATP6 to loss of function: maternally transmitted MT-ATP6 missense variants such as m.9185T>C impair proton translocation through subunit a of the ATP synthase Fo domain, lowering ATP output in peripheral nerve. Pathogenic alleles in this presentation are typically homoplasmic or carried at high heteroplasmy, and severity tracks the proportion of mutant mitochondrial genomes, the threshold behaviour familiar from the m.8993T>G NARP allele at the same gene.

Rationale:
Substituted residues in subunit a line the proton half-channel that couples rotation to ATP synthesis, so the deficit is energetic rather than toxic. Because mutant subunit a is still built into an assembled ATP synthase, how much of the impairment reflects lost proton conduction and how much reflects poor coupling within the complex is not settled, and the confidence grade reflects that unresolved point.

ClinVar Pathogenic Variants

View MT-ATP6 ClinVar Variants

MT-ATP6 OMIM Entry

MT-ATP6 OMIM

More Info

CMT-ATP6 Research Opportunity

CMT Natural History Study

Original Discovery Publication

Publication Title

A MT-ATP6 Mutation Causes a Slowly Progressive Myeloneuropathy

Authors

Bardakjian, T., & Scherer, S. S.

Publication Date
September 3, 2019

Updated: August 17, 2026 | By: K. Raymond

The Dorsal Root

More From The Dorsal Root


A Name That Does Too Much Work

Jean-Martin Charcot's name appears throughout medicine, but nowhere does it create more confusion than in the foot. Learn why the CMT foot and Charcot neuroarthropathy, also known as Charcot foot, share a name yet differ in how they develop, appear, and are managed.


When Medicine Lost Its Compass

Evidence failed not because it was wrong, but because it was weaponized. I lived the downstream effects of that failure for more than a decade. This is what happens when medicine forgets that data always ends in a human being.


Error 404: Gene Not Found

CMT genetic testing often fails to identify the cause of the disease, even when comprehensive panels are used. Here, we discuss why this happens, what genetic tests can and cannot do, and why a negative result still matters.